Akèy › Hypertension artérielle › New Jersey
Etid klinik pou Hypertension artérielle nan New Jersey
9 etid pou Hypertension artérielle ap chèche patisipan nan sit nan New Jersey.
Vil nan New Jersey
Tèks ofisyèl etid la (Anglè)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- The Cooper Health System, Camden
- Virtua Medical Group, P.A., Marlton
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06059638EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Advanced Heart Care, LLC, Bridgewater
- NJ Heart LLC, Linden
- Cardio Metabolic Institute, Somerset
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Warren, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Eatontown
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Virtua Health, Camden
- Jersey Shore University Medical Center, Neptune City
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Brick
- Clinical Trial Site, Bridgewater
- Clinical Trial Site, Flemington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109Global Paradise System US Post Approval Study
- Virtua Health, Marlton
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- CenExel HRI, Berlin
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120SPYRAL GEMINI Pilot Study
- Virtua Our Lady of Lourdes Hospital, Camden
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.